Immune-Related Adverse Events in the Setting of PD-1/L1 Inhibitor Combination Therapy
Abstract
In 2018, a multi-disciplinary workshop was held at the Massachusetts General Hospital to discuss challenges in defining, diagnosing, and treating immune-related adverse events (irAE), including those that occur in patients administered PD-1/L1 inhibitor combination therapy. In this commentary, the workshop participants present a clinical case that illustrates the complexity of irAE diagnosis and management in a patient receiving PD-1/L1...
Paper Details
Title
Immune-Related Adverse Events in the Setting of PD-1/L1 Inhibitor Combination Therapy
Published Date
Nov 21, 2019
Journal
Volume
25
Issue
3
Pages
e398 - e404
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History